Glucosylceramidase activity in fibroblasts from patients with sporadic Parkinson’s disease did not differ from controls (365 ± 30 versus 325 ± 30 nmol/mg/h, t-test P = 0.17). This evidence concerns the gene GBA1 and Parkinson disease.